These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36384972)

  • 41. A non-canonical autophagy-dependent role of the ATG16L1
    Wang C; Bauckman KA; Ross ASB; Symington JW; Ligon MM; Scholtes G; Kumar A; Chang HW; Twentyman J; Fashemi BE; Xavier RJ; Mysorekar IU
    Autophagy; 2019 Mar; 15(3):527-542. PubMed ID: 30335568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice.
    O'Brien VP; Joens MS; Lewis AL; Gilbert NM
    J Vis Exp; 2020 Dec; (166):. PubMed ID: 33346201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. S100A8/A9 is not involved in host defense against murine urinary tract infection.
    Dessing MC; Butter LM; Teske GJ; Claessen N; van der Loos CM; Vogl T; Roth J; van der Poll T; Florquin S; Leemans JC
    PLoS One; 2010 Oct; 5(10):e13394. PubMed ID: 20976233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract.
    Mysorekar IU; Hultgren SJ
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14170-5. PubMed ID: 16968784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease.
    Gilbert NM; O'Brien VP; Lewis AL
    PLoS Pathog; 2017 Mar; 13(3):e1006238. PubMed ID: 28358889
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Gilbert NM; O'Brien VP; Waller C; Batourina E; Mendelsohn CL; Lewis AL
    Front Cell Infect Microbiol; 2022; 12():909799. PubMed ID: 35782131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
    Blango MG; Mulvey MA
    Antimicrob Agents Chemother; 2010 May; 54(5):1855-63. PubMed ID: 20231390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.
    Danka ES; Hunstad DA
    J Infect Dis; 2015 Apr; 211(7):1164-73. PubMed ID: 25336727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic interactions between host and pathogen during acute urinary tract infections.
    Schilling JD; Mulvey MA; Hultgren SJ
    Urology; 2001 Jun; 57(6 Suppl 1):56-61. PubMed ID: 11378051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaginal Estrogen as First-Line Therapy for Recurrent Urinary Tract Infections in Postmenopausal Women and Risk Factors for Needing Additional Therapy.
    Chang E; Kent L; Prieto I; Eggers E; Tanner JP; Bassaly R; Wyman A; Greene K
    Female Pelvic Med Reconstr Surg; 2021 Mar; 27(3):e487-e492. PubMed ID: 33620909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.
    Guiton PS; Cusumano CK; Kline KA; Dodson KW; Han Z; Janetka JW; Henderson JP; Caparon MG; Hultgren SJ
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4738-45. PubMed ID: 22733070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and Significance of the HIP/PAP and RegIIIγ Antimicrobial Peptides during Mammalian Urinary Tract Infection.
    Spencer JD; Jackson AR; Li B; Ching CB; Vonau M; Easterling RS; Schwaderer AL; McHugh KM; Becknell B
    PLoS One; 2015; 10(12):e0144024. PubMed ID: 26658437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homeopathic medicine Cantharis modulates uropathogenic E. coli (UPEC)-induced cystitis in susceptible mice.
    de Paula Coelho C; Motta PD; Petrillo M; de Oliveira Iovine R; Dalboni LC; Santana FR; Correia MSF; Casarin RCV; Carvalho VM; Bonamin LV
    Cytokine; 2017 Apr; 92():103-109. PubMed ID: 28142108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.
    Hopkins WJ; Gendron-Fitzpatrick A; Balish E; Uehling DT
    Infect Immun; 1998 Jun; 66(6):2798-802. PubMed ID: 9596750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vesicular Cystitis: A Chronic Cystitis Variant Often Unresponsive to Antibiotics and Electrofulguration.
    Crivelli JJ; Zimmern PE
    Urol Int; 2021; 105(1-2):131-136. PubMed ID: 33070139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection.
    Hannan TJ; Mysorekar IU; Hung CS; Isaacson-Schmid ML; Hultgren SJ
    PLoS Pathog; 2010 Aug; 6(8):e1001042. PubMed ID: 20811584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uropathogenic Escherichia coli infection-induced epithelial trained immunity impacts urinary tract disease outcome.
    Russell SK; Harrison JK; Olson BS; Lee HJ; O'Brien VP; Xing X; Livny J; Yu L; Roberson EDO; Bomjan R; Fan C; Sha M; Estfanous S; Amer AO; Colonna M; Stappenbeck TS; Wang T; Hannan TJ; Hultgren SJ
    Nat Microbiol; 2023 May; 8(5):875-888. PubMed ID: 37037942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Systemic enzyme therapy for treatment of women with chronic recurrent bacterial cystitis].
    Kuz'menko AV; Kuz'menko VV; Gyaurgiev TA
    Urologiia; 2020 Apr; (2):35-40. PubMed ID: 32351061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recurrent Urinary Tract Infections: Unraveling the Complicated Environment of Uncomplicated rUTIs.
    Josephs-Spaulding J; Krogh TJ; Rettig HC; Lyng M; Chkonia M; Waschina S; Graspeuntner S; Rupp J; Møller-Jensen J; Kaleta C
    Front Cell Infect Microbiol; 2021; 11():562525. PubMed ID: 34368008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electro-fulguration for extensive inflammatory bladder lesions in post-menopausal women with antibiotic-recalcitrant recurrent urinary tract infections.
    Ma R; Chavez JA; Christie AL; Zimmern PE
    Int Urogynecol J; 2023 Jul; 34(7):1415-1422. PubMed ID: 36166061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.